BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8482619)

  • 1. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck.
    Trotti A; Klotch D; Endicott J; Ridley M; Greenberg H
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):13-21. PubMed ID: 8482619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience.
    Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
    Head Neck; 1993; 15(2):87-96. PubMed ID: 8440619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial.
    Trotti A; Klotch D; Endicott J; Ridley M; Cantor A
    Head Neck; 1998 Mar; 20(2):119-23. PubMed ID: 9484942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
    Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
    Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma.
    Ravasz LA; Slootweg PJ; Hordijk GJ; Smit F; van der Tweel I
    J Craniomaxillofac Surg; 1991 Oct; 19(7):314-8. PubMed ID: 1752972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of postoperative CHART and CHARTWEL in head and neck cancer.
    Shah N; Saunders MI; Dische S
    Clin Oncol (R Coll Radiol); 2000; 12(6):392-6. PubMed ID: 11202092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study.
    Huang DT; Johnson CR; Schmidt-Ullrich R; Grimes M
    Int J Radiat Oncol Biol Phys; 1992; 23(4):737-42. PubMed ID: 1618666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.